An oncology researcher has made an unexpected contribution to the understanding of type 2 diabetes. In results published in Science…
Home »
Moleculin Files with FDA for Expedited Approval Pathway for Annamycin
HOUSTON, TX / ACCESSWIRE / March 13, 2019 / Moleculin Biotech, Inc., (NASDAQ: MBRX) ("Moleculin" or the "Company"), a clinical…
TGF-beta pathway protects against uterine cancer
Two new mouse models of uterine cancer shed light on how this disease—the most common gynecological cancer in the U.S.…